Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2400092109Phase 4Recruiting
Phase 4 trial of oliceridine and sufentanil in acute pain (2 arms), sponsored by Wu Jieping Medical Foundation Committee. Primary endpoint: Numeric Rating Scale. Started Nov 2024; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2400092109.